Page last updated: 2024-12-05

9,10-diphenylanthracene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID15159
CHEBI ID51676
MeSH IDM0135825

Synonyms (33)

Synonym
AC-5809
unii-51bq8iyq9u
51bq8iyq9u ,
c26h18
nsc-24861
nsc24861
1499-10-1
9,10-diphenylanthracene ,
anthracene,10-diphenyl-
inchi=1/c26h18/c1-3-11-19(12-4-1)25-21-15-7-9-17-23(21)26(20-13-5-2-6-14-20)24-18-10-8-16-22(24)25/h1-18
anthracene, 9,10-diphenyl-
9,10-diphenylanthracene, 97%
nsc 24861
einecs 216-105-1
D1689
A808976
AKOS004902510
FT-0621601
CHEBI:51676
DTXSID1061734
SY015328
mfcd00001253
Q-200567
9,10-diphenyl anthracene
D4401
1449-10-1
GS-6658
9,10-diphenylanthracene, analytical standard
9,10-diphenylanthracene, 98%
9,10-diphenyl-anthracen
CS-W011960
Q274986
9,10-diphenylanthracene (purified by sublimation)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Our data indicate an urgent need for LS waste management guidelines and for adequate information regarding toxic outcomes that may arise from human exposure."( Luminescent threat: toxicity of light stick attractors used in pelagic fishery.
Bagattini, R; Barretto, FP; Bechara, EJ; da Silva, AL; de Arruda Campos, IP; de Medeiros, MH; de Moura, RA; de Oliveira, AA; de Oliveira, TF; Di Mascio, P; Loureiro, AP, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
photosensitizing agentA chemical compound that can be excited by light of a specific wavelength and subsequently transfer energy to a chosen reactant. This is commonly molecular oxygen within a cancer tissue, which is converted to (highly rective) singlet state oxygen. This rapidly reacts with any nearby biomolecules, ultimately killing the cancer cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
anthracenesCompounds containing an anthracene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.11)18.7374
1990's3 (11.11)18.2507
2000's5 (18.52)29.6817
2010's12 (44.44)24.3611
2020's4 (14.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.35 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]